Use of semaglutide after acute coronary syndrome: an exploratory retrospective study
{{output}}
Aims: Semaglutide, a glucagon-like peptide-1 receptor agonist, has demonstrated cardiovascular benefit in patients with type 2 diabetes mellitus (T2DM) and established atherosclerotic disease. Its role in the immediate postacute ... ...
